CPA
ORGS

Cowen Prime Advisors’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Cowen Prime Advisors’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-50
Closed -$2K – 191
2018
Q4 		$2K Buy
+50
New +$2.87K ﹤0.01% 173

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.25B AUM 19.46% 1-Year Est. Return
TFGT
TS Financial Group (TSFG) Lake Forest, Illinois $794M AUM 24.65% 1-Year Est. Return

Cowen Prime Advisors's ORGS Position: Q1 2019 in Review

Cowen Prime Advisors sold out of Orgenesis Inc. Common Stock (ORGS) in Q1 2019, closing a stake of 50 shares — an estimated $2K sold.

Cowen Prime Advisors first reported a position in ORGS in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 18 funds tracked by Wall St. Rank hold ORGS as of Q1 2019.

  • Cowen Prime Advisors reported no remaining Orgenesis Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Cowen Prime Advisors sold 50 Orgenesis Inc. Common Stock shares in Q1 2019, an estimated $2K.
  • Cowen Prime Advisors first reported a position in Orgenesis Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Cowen Prime Advisors's Orgenesis Inc. Common Stock position peaked at $2K in Q4 2018.
  • 18 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q1 2019.

Based on Cowen Prime Advisors's 13F filing for Q1 2019, filed 29 Apr 2019.